NCT04149600View on ClinicalTrials.gov

Identification of Genetic Causes of Calcific Aortic Valve Disease

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Calcific Aortic StenosisCalcific Aortic Stenosis - Bicuspid ValveAortic Valve DiseaseAortic Valve CalcificationAortic DiseasesAortic AneurysmAortic Valve Cusp AbnormalityAortic Valve Disease MixedAortic Valve Insufficiency
Interventions
PROCEDURE

Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study.

Adult patients undergoing aortic valve replacement (AVR) and/or aortic resection will be enrolled.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT04149600 - Identification of Genetic Causes of Calcific Aortic Valve Disease | Biotech Hunter | Biotech Hunter